Importance of SALL4 in the development and prognosis of hepatocellular carcinoma

Table 4 Multivariable analysis results in postoperative hepatocellular carcinoma patients

Parameters	P value	Relative risk	95%CI
Clinical stages	0.002	1.547	1.169-2.047
histological differentiation	0.003	1.823	1.218-2.728
BCLC stage	0.876	1.028	0.725-1.459
AFP	0.046	1.158	1.002-1.338
Tumor size	0.503	1.133	0.786-1.635
Vascular invasive	0.531	0.796	0.389-1.627
SALL4	0.029	1.301	1.028-1.646

SALL4: Sal-like protein 4; AFP: α-fetoprotein.